Reference

CEM/CMO/2021/021

Name

COVID therapeutic alert – update to interim clinical commissioning policy - on the use of neutralising monoclonal antibody and intravenous antiviral treatments for non-hospitalised patients with COVID infection

Categories

Scottish Government Drug Alerts

Organization

Scottish Government Health and Social Care Directorates

Keywords

NHS SCOTLAND DRUGS SAFETY RISKS PHARMACEUTICAL INDUSTRY DRUG THERAPY PHARMACEUTICAL SERVICES

Description

Attaches a letter reminding clinicians that treatments should only be offered where the patient is not already showing signs of clinical improvement and to provide further clarity on haematological disease (appendix 1) and the chemotherapy agents (appendix 2) relevant to determining patient eligibility for dissemination to relevant healthcare professionals for onward transmission.

Contact Name

Contact Email

Contact Address

Contact Phone

Created

2021-12-24 00:00:00

Download URL